Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Clinical Ophthalmology Volume 13, 2019 - Issue

Submit an article Journal homepage

Open access

103

Views

CrossRef citations to date

Altmetric

ORIGINAL RESEARCH

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration

Naoko Koike1 Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan

Tsuyoshi Otsuji1 Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, JapanCorrespondence[email protected]

Akiko Tsumura1 Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan

Katsuaki Miki1 Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan

Yukio Sakai1 Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan

Tetsuya Nishimura1 Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan

Kanji Takahashi2 Department of Ophthalmology, Kansai Medical University, Osaka, Japan

show all

Pages 1247-1251 | Published online: 15 Jul 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (3)

Michel Giunta, Louis-Pierre Gauvin Meunier, Donald Nixon, Jeff Steeves & Jason Noble. (2022) Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review. Clinical Ophthalmology Volume 16, pages 2885-2894.
Crossref

Christof Haensli, Isabel B. Pfister & Justus G. Garweg. (2021) Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes. Journal of Clinical Medicine 10:12, pages 2666.
Crossref

Keiichiro Tanaka, Yasuharu Oguchi, Tomoko Omori, Yumi Ishida, Hiroaki Shintake, Ryutaro Tomita, Akihito Kasai, Masashi Ogasawara, Yukinori Sugano, Kanako Itagaki, Akira Ojima, Takeshi Machida, Hideharu Sekine & Tetsuju Sekiryu. (2021) Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease. Scientific Reports 11:1.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references